Force Health Protection Guidance (Supplement 20) Revision 1 - Department of Defense Guidance for Personnel Traveling During the Coronavirus Disease 2019 Pandemic

UNDER

SECRETARY

OF

DEFENSE

4OOO

DEFENSE

PENTAGON

WASHINGTON,

D.C.

20301.4000

JAN

I

0

2022

PERSONNEL

AND

READINESS

MEMORANDUM

FOR

SENIOR

PENTAGON

LEADERSHIP

COMMANDERS

OF THE

COMBATANT

COMMANDS

DEFENSE

AGENCY

AND

DOD FIELD

ACTIVITY

DIRECTORS

SUBJECT:

Force

Health Protection

Guidance (Supplement

20)

Revision

1

-

Department

of

Defense

Guidance

for Personnel

Traveling

During

the

Coronavirus

Diseas

e 2019

Pandemic

This

memorandum

supplements

requirements

in references (a)t

through

(c)

and rescinds

and replaces

references (d)

and

(e).

This memorandum

applies

to

official

and unofficial

travel

and

provides

updated

pre-

and

post-travel

guidance

for

purposes

of force

health

protection

(FHP)

for

Service

members,

DoD

family

members,

DoD

civilian

employees,

and DoD contractor

personnel.

The

heads

of Office

of

the Secretary

of

Defense (OSD)

and DoD

Components

will

ensure that

all

actions

comply

with applicable

labor

obligations

to the

extent

such obligations

do

not

conflict

with

the Department's

ability

to conduct

operations

during this

emergency,

consistent

with

the law.

The

Secretaries

of the Military

Departments (MILDEPs),

heads

of OSD Components,

and

Commanders

of

the Geographic

Combatant

Commands

(GCCs)

may implement

more

restrictive guidance

and

additional

FHP

measures

based

on mission

requirements

and local

risk

assessments,

in consultation

with

their medical

staffs and

public

health

authorities.

The

Secretaries

of the MILDEPs,

heads

of OSD

Components,

Commanders

of the

GCCs,

and

the Commander,

U.S. Transportation

Command,

may

choose

to exempt

assigned

aircrew

and aircraft

maintenance

recovery

team

members

on commercial,

military

contracted,

and

organic military

airuaft

from

this

guidance,

to the extent

permissible,

consistent

with applicable

legal

requirements.

In

addition,

patients

and their

attendants

in

the en-route

care

system are

exempt

from

restriction

of movement (ROM)

requirements

and may

be exempted

from

testing

requirements

by the Theater

Validating

Flight

Surgeon

until

they arrive

at their fìnal

treatment

destination.

Medical

care

will not

be

delayed

due to RoM

requirements.

Attachment

1

provides

guidance

for

travel

within the

United

States

and to and

from

foreign countries.

Adherence

to this

guidance

will

protect

the

health

of

personnel

and reduce

the

spread of

coronavirus

disease 2019

(COVID-l9)

within

and

outside the

United

States.

This

memorandum

and other

COVID-I9 guidance

memoranda

are

centrally located

at:

https://www.defense.gov/Spotlights/Coronavirus-DOD-Response/Latest-DOD-Guidance/.

I

References

are listed in

Attachment

2.

Please

direct

any

questions

or cornments

to the following

email address

dha.ncr.ha-support.

list.policy-hrpo-kmc-owners

@mail.rnil.

Gilbert

R.

Cisneros,

Jr.

Attachments:

As stated

,,

ATTACHMENT

1

General Travel

Guidance

During

all official

travel,

travelers will

follow

all applicable Federal,

State, local,

host

nation

(HN),

and commercial

air carrier requirements,

including

mask wearing

and

physical

distancing. Travelers

will follow

any requirements

in

the Electronic Foreign

Clearance Guide

pertaining

to entry,

movement,

or operations into

a HN.

Travel requirements

or

recommendations

are listed

below

by travel

destination

(within

or outside

the United States),

type of travel

(official

or

unofficial),

and

person

traveling

(Service

member,

DoD family

member, DoD

civilian employee,

or DoD

contractor

personnel).

The

term "United

States"

means the

50 States,

the District

of Columbia,

U.S. Territories,

and

Commonwealths.

For travel

via military

airlift

(contracted

or organic), Aerial

Point

of

Embarkation

(APOE)

health

screening is

mandatory.

Travelers

who have

a medical issue identified

during screening,

or who refuse

to be screened

at

the APOE, may

be denied

travel.

The waiver

authority

available to

the Secretaries

of the MILDEPs,

heads

of OSD

Components,

Chief

of the National

Guard Bureau,

and

Commanders

of the GCCs for

offrcial

travel is specified

in the "Specific

Travel

Guidance

by Type

of Travel" section

below. Travel

that is limited

to transit

between,

and through,

foreign

countries contained

wholly

within a

single

GCC area

of responsibility,

and

between GCC

areas of responsibility,

is

not subject

to this

memorandum

and will be

managed by

each relevant

GCC

or GCCs as appropriate.

Risk

Assessment

Prior

to Travel

It

is important

for the

appropriate

commander

or supervisor,

assisted by medical

personnel,

to complete

a

risk

assessment

for

each traveler

before travel,

as set forth

below,

including

an

assessment

of the health

status and itinerffy.

Specifically:

For

Service members,

a risk

assessment

is required

before all travel

For DoD

family members,

reimbursement

for official

travel may

only occur after

the

Service member

certifies,

to the

best of his

or her knowledge,

that family

members

have

completed

a risk

assessment. DoD

family members

are

strongly encouraged

to

complete

a risk

assessment

before unofficial

travel

as well.

For DoD

civilian

employees,

a risk assessment

is required

before

official travel.

DoD

civilian

ernployees

are strongly

encouraged

to complete

a risk assessment

before

unofficial

travel

as

well.

For DoD

contractor

personnel,

DoD

contracting

officers will

ensure

that all contracts

that include

performance

requiring

official

travel outside the

United States require

DoD

contractor

personnel

to

complete

a

risk

assessment. DoD

contractor

personnel

are strongly

encouraged

to complete

a risk

assessment before

unofficial

travel as well.

a

o

J

The risk

assessment

of the health

status of

the traveler

will include,

at aminimum,

determining:

a

Whether

the individual

is familiar

with how

to

self-monitor,

and what

actions to

take,

if

he or she

develops

signs

or symptoms consistent

with COVID-19

or

contracts

COVID-19;

Whether the individual

has

exhibited

any signs

or symptoms

consistent

with

COVID-

19 within

the

days;

Whether

the individual

has

had close

contact,

as defined in

reference

(f),

with

anyone

having,

or known

to have

exhibited,

signs or symptoms

consistent

with

COVID-I9,

or who has

tested

positive

for

COVID-19

within the

days;

Whether

the

individual

has recently

recovered

from

COVID-19

and, if so,

when and

if

they have

documentation

of a

positive

viral test

and documentation

of recovery

from

a health

care

provider;

a

Whether

the individual

is

fully

vaccinated as

defined in reference

(o)

and, if so,

when,

and

whether they

have

proof

of vaccination

(i.e.,

Centers for Disease

Control and

Prevention (CDC)

vaccination

card or other

medical

documentation);

Whether

the individual

has traveled

to a country,

State,

territory,

county, or

city with

high

or

increasing

risk of

CovID-19

as defined

by the cDC

in Travel

Health

Notices;

a

Whether the

individual

is at increased

risk

of severe illness

of COVID-19

as

defìned

by

the CDC. Additional

details can

be found

at

https://www.cdc.gov/coronavirus/2Dt9-ncovlneed-extra-precautions/index.html;

and

a

The

status

of community

spread

of COVID-l9

for the

travel destination.

In

all cases,

no

personnel

should

travel if

they have

tested

positive

for COVID-l9

and

have

not

yet

met the

criteria for

discontinuing

isolation,

they

are symptomatic,

or they

are

pending

COVID-l9

test

results. Travel

should

also

be delayed if, in

the

past

14

days,

an

individual

has

been in close

contact,

as defined in

reference

(f),

with

someone who

has tested

positive

for,

andlor

been

symptomatic

of, COVID-19

and requires

self-quarantine,

unless

exempted

based on

prior

COVID-l9

infection

or

prior

completion

of COVID-I9

vaccination,

per

reference

(f).

Prior to

travel, all

travelers

should be

educated on how

to self-monitor

and what

actions

to take if

one develops

signs or symptoms

consistent

with COVID-I9

or contracts

COVID-19.

In

addition

to

personal

health

protective

measures

that have

been implemented

throughout

DoD

(references

(b)

and

(g)),

strict adherence

to ROM

guidelines

is effective

in

limiting

COVID-19

transmission.

Travel-associated

ROM

requirernents

are

specified within

this

4

attachment.

All definitions for

travel-related

terms may

be found in

the

DoD

Joint

Travel

Regulations

(reference

(h)).

Steps to Be

Taken During

ROM

During

any required

or recommended

ROM

period,

individuals

(with

the

exceptions to

ROM noted

below)

will, to the

fullest

extent

practicable:

Observe

applicable

HN requirements

in

a manner

consistent with

existing

agreements

or affangements

if

HN ROM requirements

are more

stringent.

Restrict

movement

to their residence

or other appropriate

domicile2

as much

as

possible.

Maintain

a

distance

of

greater

than

6 feet from

anyone

who did not, or

will not, travel

with

them, including

family

members

or roommates;

wear masks

at all times

around

individuals;

and employ

hand

washing

practices

in

accordance

with CDC

guidance;

avoid

crowds;

avoid the

use of

public

transportation;

and avoid close interaction

with

pets

or other animals.

Adhere

to strict

FHP measures

for 14

days after travel

even if

the ROM

period

is

shorter than

14 days.

Consider their

ROM location

as their authorized

duty location.

Self-monitor

for

subjective

fever

(that

is, feeling

feverish)

or actual fever

(>100.4oF

or

>38'C)

by taking

their temperature

twice

a day, and

self-monitor for

cough,

difficulty

breathing,

or

other covlD-19

signs

and symptoms

as described

by the

CDC at

:

https

://www.cdc. gov/coronavirus/2O

19

-ncov

lsympto ms-

testing/symptoms.html.

If signs

or symptoms

consistent

with COVID-I9

develop

during

the l4-day

self-monitoring period,

individuals

will,

to the fullest

extent

practicable,

immediately

self-isolate

in

accordance

with CDC

guidance,

limit

close

contact, as

defined in reference

(f),

with

others, seek

advice by telephone

or other

authorized

communication

modalities

from

an appropriate

healthcare

provider

to

determine

whether

medical

evaluation

and testing

for COVID-19

is needed,

and

retum

to

work only

when cleared

by a health

care

provider

to do

so.

For

Service

members,

notify their

chain

of command

or supervisor if

they, or

persons

in

their household,

develop

signs

or symptoms

consistent

with covlD-19.

Such

health

information

will

be used only

for FHP

purposes

and

will be

protected

in

accordance

with

applicable laws

and

policy.

o

a

o

a

DoD

civilian employees

should notiff

supervisors

if they

develop, or have had

contact

with anyone

who exhibits,

signs

or symptoms

consistent

with COVID-19.

Such health information

will be

used only for

FHP

purposes

and will

be

protected

in

2

The ROM

location

for Dynamic Force

Employment

organizations and individuals

will be identified

through a

case-by-case

determination

coordinated

with

the force

provider

and

GCC.

a

5

accordance

with

applicable laws

and

policy

O

Telework when

practicable

per

direction

of their commander

or supervisor

For

personnel

whose

presence

is required

in

the worþlace

by their

supervisor,

consider whether

and when

to retum

to work

during the ROM

period

in accordance

with reference

(b).

Additional ROM

Guidance:

If RoM

is

conducted

prior

to travel,

travel

to and from

an APOE following

RoM

completion

will,

to the maximum

extent

possible,

be conducted

in a manner

that

minimizes

the risk

of

personnel

being

exposed to,

or contracting,

the virus that

causes

COVID- I

9 during travel.

For

MILDEP

ships and

submarines,

underway

time from

port

of

embarkation/debarkation

to

port

of debarkation/embarkation

may

be used to meet

ROM

requirements provided

no

cases have

occurred

while underway and

there has

been no

contact

with

personnel

from

other vessels

(e.g.,

resupply

vessels) that

would

permit

transmission.

o

Exceptions

to ROM:

o

Unless otherwise

required

by

a more restrictive

DoD

policy, pre-

and

post-travel

ROM

is not required

for individuals

who have

fully recovered from

a laboratory-

confirmed

diagnosis

of COVID-I9

within

the

prior

to travel,

or

for

individuals

who are

fully vaccinated.

Those

fully recovered

and fully

vaccinated

will

self-monitor

for

COVID-19

symptoms after

travel and will isolate

and

get

tested for

COVID-19

if they develop

signs

or symptoms consistent

with

COVID-19.

o

O

ROM after

arrival

at the travel

destination

may

or

may

not be required

by the

destination

health

authority

(e.g.,

the HN

or State

or

local

jurisdiction)

if travelers

have

undergone COVID-

19

testing

prior

to travel.

If the relevant

GCC requires

a ROM upon

arrival in the

country as

a

means

of respecting

HN law,

then

a

pre-deployment

ROM is

not required.

Travelers

should

consult

the Electronic

Foreign

Clearance

Guide

(https://www.fcg.pentagon.miUfcg.cfm)

and

check with

the MILDEPs,

GCCs,

State

and local

public

health

authorities, and military

installations

for current information.

Testing

Guidance3

Pre-travel, post-travel,

and ROM-associated

COVID-19 testing

is authorized

for official

domestic and international

air travel

at military

medical treatment

facilities

on a non-

reimbursable

basis in accordance

with references (Ð,

0),

and

(1)

for Service

members, DoD

civilian

employees, DoD

contractor

employees

who

are traveling for

official DoD

business,

3

For

DoD testing

guidelines,

refer to references

(Ð, (Ð,

û),

(k),

and

(l).

6

members

of the Selected

Reserve

(including

members

of the National

Guard), and family

members

approved

to accompany

DoD

personnel.

Testing

is

authorized for

official travel

on

presentation

of an

electronic or

paper

copy

of orders at

military medical

treatment facilities

in

accordance with

this

guidance

and

per

reference

(k).

Personnel

(with

the

exceptions to

testing noted

below) conducting

official

international

air travel

will adhere

to the testing

indicated

below and maintain proof

of the negative

test

during

travel. Pre-travel

testing is consistent

with

references

(m)

and

(n).

If the destination

location requires

a specific

test or stricter

test timing,

personnel

must

follow

the destination

location requirement

instead,

which may

be

reflected

in

the Electronic

Foreign

Clearance Guide.

For military flights, personnel

will follow

this

guidance

on

pre-travel

testing

unless

operational

circumstances

cannot accommodate.

Pre-travel

virala

testing is required

1

to 3 days

prior

to departure

of the commercial

or

military

airlift for

both travel from

the

United States

to a foreign

country or from

a

foreign

country

to the

United States.

Travelers

arriving

without

a valid negative

COVID-19

test, vaccination,

waiver,

or

proof

of recovery

from COVID-I9,

as

required

by their destination,

will

be denied

travel.

Post-international

travel viral testing

3 to

5 days after the

completion

of travel is

recommended

for Active Duty

Service

members

and DoD

civilian employees.

Active

Duty

Service members

(with

the exceptions

to testing noted

below)

conducting

unofficial

international

air travel

will adhere

to the testing

indicated

below and maintain

proof

of the negative

test

during

travel. Active Duty

Service

members

are authorized

to receive

pre-

travel and

post-international

travel

testing in

accordance

with references

(i),

G),

and applicable

MILDEP

guidance.

Pre-travel

viral

testing is recommended

I to 3 days

before departure

of the

commercial

or military

airlift

for travel from

the United

States

to a

foreign

country.

Travelers

will adhere

to the destination

testing

requirements.

a

o

Pre-travel

viral testing is

required I

day before

departure

of the commercial

or

military

airlift for

travel from

a foreign

country to the

United States.

Post-international

travel viral

testing 3

to 5 days after

the completion

of travel is

recommended

for Active

Duty

Service members

and DoD

civilian

employees.

a

Testing in

this

guidance

refers to

tests that

utilize molecular

or, in certain limited

circumstances,

antigen

testing

methods, in

accordance

with reference

(j).

o

7

Exceptions

to Testing:

Unless

otherwise required

by

a more restrictive

DoD Policy

or

stated in

the Electronic Foreign

Clearance

Guide:

Individuals

fully recovered

from a laboratory-confirmed

diagnosis

of COVID-I9

infection

within

the

are not required

to undergo

viral testing

and

may instead

travel

with documentation

of recovery from

COVID-l9

that includes:

o Their

positive

COVID-19

viral

test result

on a sample

taken no more

than 90 days

before the flight's

departure

from

a foreign

country; and

o A

letter from

a licensed health

care

provider

or a

public

health

official stating

that

the individual

is

cleared to

travel.

a

Individuals

who

are

fully

vaccinated

are

exempt from

viral testing

prior

to travel

from

the

United States

to a foreign

country,

unless there is

an applicable,

explicit HN

requirement

requiring

such testing.

Fully

vaccinated

personnel

are required

to undergo

viral testing

prior

to travel from

a

foreign

country

to the United

States and

post-international

travel testing

as indicated

above.

Additional guidance:

"Dat''for

purposes

of this

guidance

is

a calendar

day

The 1-day

time frame

is I

day before

the flight's

departure

(e.g.,

if individuals

subject

to testing

under this

guidance

are scheduled

to depart

a

foreign

country

at l:00 PM

on

a Friday, they

can board

the flight

with a negative

test that was

taken any

time on the

prior

Thursday).

If a trip

from the

United States

to a foreign

country is

shorter than 1

day, aviral test

taken in

the United

States can

be used if the

specimen was

taken no more

than I day

before the return

flight

to the United

States departs.

a

Testing

requirements

for

connecting

flights:

o Individuals

subject to testing

under

this

guidance

who are connecting

through

the

United

States

to another country

must

be tested for

COVID-19.

o Individuals

subject

to testing

under this

guidance

who have

one or more

connecting

flights to

get

to the

United States

must have their

COVID-I9

test

taken

within 1

day before

the departure

of their first

flight.

o Individuals

subject to testing

under

this

guidance

who travel from

a U.S. State

or

territory

to another

U.S. State

or territory,

but have to

connect through

a foreign

country

(e.g.,

traveling

between

the Northern

Mariana Islands

and the

U.S.

mainland

via

Japan) are not

required

to be tested

for COVID-19.

Testing requirements

for delayed

flights:

o Individuals

subject

to testing

under this

guidance

are not required

to

be

retested

for

COVID-19 if

their first

flight is

delayed

past

the 1-day limit

of testing due

to

8

a

a situation

outside of their

control

(e.g.,

delays because

of severe weather

or

aircraft mechanical

problem),

and that delay is 24

hours or less

past

the 1-day

limit for testing.

o

Individuals

subject to testing

under this

guidance

are not required

to be retested

for

COVID-19 if

their connecting

flight is delayed

past

the 1-day limit

of testing

due to

a situation outside

of their

control

(e.g.,

delays

because of severe

weather

or aircraft mechanical problem),

and that

delay is 48

or

fewer hours

past

the 1-

day limit for

testing.

o Individuals

subject

to testing under

this

guidance

must be retested for

COVID-19

if their

connecting flight is

delayed

past

the 1-day limit

of testing due

to a

situation

outside of their

control

(e.g.,

delays

because

of

severe

weather

or aircraft

mechanical problem),

and that

delay is more

than 48 hours

past

the 1-day limit

for testing.

Specific Travel

Guidance

by Type

of

Travel

from the

United States

to a Foreim Country

a) Official

Travel

(as

set forth in reference

(h))

i)

Service

members:

o

V/ill conduct

a travel-associated

ROM as follows

unless a ROM

exception

described

above

applies:

o Upon

arrival at

the

foreign

country

destination:

'

Service

members will

observe applicable

HN

public

health

measures.

.

ROM

will be conducted

as

follows:

assessment, the head

of an OSD

Component or

Secretary of a

MILDEP

may, consistent

with applicable

HN

public

health

measures,

decrease to

a

ROM

for 7

days with a negative

viral test

within

48

hours

prior

to the

end of the 7-day

ROM.

and movement,

including

the mode of transportation

to final

destinations,

are executed.

'

For any

travel-associated

ROM, follow

the

procedures

specif,red above in

the

"Steps

to

Be

Taken during

ROM" section.

o If it is

necessary

to undertake a

pre-arrival

ROM to

observe applicable HN

public

health

measures,

the Service member

will follow

the 1O-day or 7-day

ROM

procedures

described

above at an

appropriate domicile

prior

to

departure and

complete

pre-travel

testing

within

1

to 3 days

prior

to departure.

o Only

one ROM is required,

either

before travel

or after arrival.

o Must follow

all other requirements

imposed

by the GCC

with responsibility

over the

destination

geographic

area, all

applicable HN

procedures,

and all

requirements

of the Electronic Foreign

Clearance

Guide.

ii) DoD

family members:

o

Service

members must

attest that, to the

best of their knowledge,

their

family

members have

followed

the same requirements

as those set forth

for Service

members

in this

guidance.

Failure

to do so may result

in delay or

cancellation

of

9

previously

authorized

travel.

This

attestation

requirement

will be incorporated

into

travel

orders

issued

to Service

members.

iii) DoD

civilian

employees:

o

Will

conduct

a

travel-associated

ROM

and other

FHP

practices

as described

above

for Service

members.

iv)

DoD

contractor

personnel:

o

DoD

contracting

officers will

ensure

that

all contracts

that include performance

outside

the United

States

require

DoD

contractor personnel

to comply

with

the

country

entry requirements

of

the respective

GCC

(which

may

include

screening,

ROM,

and

testing),

as reflected

in

the Electronic

Foreign

Clearance

Guide,

and

all

applicable

HN

procedures.

The

GCC may

waive

such additional

requirements,

consistent

with

existing

authorities.

b) Unofficial

Travel

(as

set forth in

reference

(h))

i)

Service

members

will

comply

with

their respective

MILDEP

guidance,

DoD

Component-specific guidance,

and/or

GCC

and applicable

HN

procedures

for

the

areas

to which,

and

through

which,

they

are traveling.

ii) DoD

family

members,

DoD

civilian

employees,

and

DoD

contractor

personnel

should

comply

with the

guidance

and/or

applicable

HN

procedures

for

the areas

to

which,

and

through

which,

they

are traveling,

and are

strongly recommended

to follow

the

FHP

guidance

provided

within

this

document

and

any other DoD

Component-specific

guidance.

2. Travel

or Throush a F

Countrv

to the

United

States

a) Official

Travel

(as

set forth in

reference

(h))

Ð

Service

members:

o

V/ill conduct pre-travel

screening

and testing

as described

above,

prior

to

departure.

If COVID-I9

infection

is indicated

by the

screening

or testing,

delay

travel

and

consult

a health

care

provider

for

clearance

to

travel.

o

Will

conduct

a risk

assessment

as described

in "Determining

Whether

to

Travel"

above

upon

arrival in

the

United

States. Those

who become

ill, or have

had

close

contact

with a

person

known

to have

contracted

COVID-19,

during travel

will

follow

the

requirements

in

reference

(b).

o

ROM

will be

conducted

as follows:

Unless

a ROM

exception

described

above

applies,

if traveling

from

or having

traveled

through

a foreign

country,

the

Service

member

will,

upon arrival

at

his or her

destination

domicile:

o

ROM

for at least

10

days

without testing.

'

After

an appropriate

risk

assessment,

the

head

of the OSD

Component

or

Secretary

of

the MILDEP

concemed

may

decrease

to a ROM

for 7

days

with a negative

viral

test within

48 hours prior

to the

end of the

7-day

ROM.

Testing

associated

with

the

7-day ROM

will meet the

requirement

for a

separate test

3

to 5 days

after arrival.

'

Personnel

whose

presence

is required

in

the worþlace

by their

supervisor

may return

to work

during

the ROM

period

in accordance

with reference

(b).

o

For any

travel-associated

ROM,

follow

the

procedures

specified

above

in

the

"Steps

to Be

Taken

During

ROM"

section.

The

ROM requirements

may

be

10

reduced

or

waived by the

appropriate head

of an OSD

Component

or

Secretary

of a MILDEP

on

a case-by-case

basis with appropriate

risk

assessment

and

mitigation

measures.

o Comply

with all installation,

State, and local

government

guidance.

o

Be tested,

between

3 and 5 days

after arrival, for

COVID-19.

Vaccinated

personnel

are not exempt

from

post-international

travel viral

testing.

ii)

DoD family

members

will conduct pre-travel

screening

and testing

as described

above and

are strongly

recommended

to follow

the FHP

guidance

that is

provided

within

this document

for

Service

members during

all travel.

iii) DoD

civilian

employees

and DoD

contractor

personnel

will conduct

pre-travel

screening

and testing

as described

above and are strongly recommended

to follow

the

FHP

guidance

that is

provided

in

this document

for Service

members during

all

travel.

Any

applicable requirements

in reference

(b)

must

be met

prior

to returning

to

a DoD

worþlace.

b) Unofficial

Travel

(set

forth

in reference

(h)

i)

Service members:

o

Will

conduct

pre-travel

testing

as described

above

and follow

pre-travel

screening

and risk

assessment

and ROM

procedures

described above

in the Official Travel

section.

o

Will comply

with DoD

Component-specific guidance

andlor

procedures

of the

GCC

and HN

applicable

to the countries

to which,

and through

which, they are

traveling.

o

Will

conduct

a

risk

assessment

as described

in

"Determining Whether

to Travel"

above

upon arrival in

the United

States. Those

who become

ill, or have had

close

contact

with

a

person

known

to have

contracted

COVID-19

during travel, must

"

self-isolate

(if

ill)

or

quarantine

(if

exposed

but not ill)

and notifu

their chain

of

command

or supervisor.

Exception:

Individuals

fully recovered

from

a

laboratory-confìrmed

diagnosis of

COVID-19 infection

within

the

months

or those

who are fully

vaccinated

arc not required

to

quarantine

as long

as

they remain

s¡rmptom-free.

ii)

DoD family

members

are

strongly recommended

to follow

the FHP

guidance,

including

pre-travel

screening,

provided

within this document

for

Service members.

iii) DoD

civilian

employees

and DoD

contractor

personnel

are

strongly recommended

to

follow

the FHP

guidance,

including pre-travel

screening

provided

within this

document

for

Service members.

Any

applicable requirements

in reference

(b)

must

be met

prior

to returning

to a DoD

workplace.

3. Travel

Within the

United States

a) Official Travel

(as

set forth in reference

(h))

i)

Service

members:

.

May conduct

unrestricted

travel

between installations

that meet

the criteria set

forth

in reference

(c).

Prior

to travel,

Service members

should consult

the

COVID-19

Travel Restrictions

Installation

Status Update,

available

at:

https

://www.defense.gov/Spotlights/Coronavirus-DoD-Response/.

o

Will comply

with military

installation,

State, and local

government

travel

restrictions.

ll

.

Will

comply

with

their DoD

Component-specific guidance

and/or

procedures

for

screening,

ROM,

and testing,

and should

review

and consider

CDC

guidance.

Testing

is

authorized

in accordance

with reference

fi).

ii) DoD

family

members

are strongly

recommended

to follow

the FHP

guidance

provided

within this

document

for

Service members

during all

travel.

iii)

DoD

civilian

employees

and DoD

contractor personnel

will conduct

pre-travel

screening

as described

above and

are

strongly recommended

to follow

the

guidance

provided

within this

document

for

Service

members

during

all travel. Any

applicable

requirements

in reference

(b)

must

be met

prior

to retuming

to

a

DoD

worþlace.

b)

Unofficial

Travel

(as

set forth

in reference (h))

Ð

Service

members:

o

Should

consult the

COVID-19

Travel

Restrictions

Installation

Status Update

available

at

https://www.defense.gov/Spotlights/Coronavirus-DOD-Response/

prior

to travel.

o

Will

comply

with military

installation,

State,

and local

government

travel

restrictions.

o

Will

comply

with their DoD

Component-specific guidance

and/or

procedures

for

screening,

ROM, and

testing.

ii) DoD

family

members

are

strongly

recommended

to follow the

FHP

guidance

provided

within

this

document

for Service

members

during all

travel.

iii) DoD

civilian

employees

and DoD

contractor personnel

are

strongly recommended

to

follow

the

guidance

provided

above for

Service

members.

Any applicable

requirements

in reference

(b)

must

be met

prior

to

returning

to a DoD

worþlace.

Additional

Guidance

to

Assist

commanders

with rravel

Decisions:

The Department

of Defense

Joint

Travel

Regulations

are available

at:

https

: //www.defensetravel.

dod.miVsite/travelre

g.cfm

The DoD

COVID-19

Response

and

Operations Platform,

available

at https://covid-

status.data.miJl#|, provides

travel

scenarios

and

COVID-19 installation

status and

information

to scope,

plan,

and approve

travel

by

providing

awareness

of Health

Protection

Condition

levels

and COVID-l9

hotspots.

The Defense

Health Agency's

Armed Forces

Health

Surveillance

Division provides

a

"Trajectory

of

Civilian

COVID-l9

Cases

by County''

for the

United

States at

the

AFHSB

COVID-I9

Dashboard,

available

at:

o

https://go.intelink.gov/25B\ilvsS

o

https ://covid-status.d

ata.miV#

/

Travel

Restriction

Installation

Status

Updates,

available

at:

https

: //www.

defens e.

gov/Spotlights/C

oronavirus-D

OD-Respons

e/

COVID-l9

Signs and

Symptoms

are

available

at:

https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testingisymptoms.html

a

o

t2

Additional

Guidance for

Reserve

and National

Guard Personnel:

The

Secretaries

of the

MILDEPs may issue

any additional

procedural guidance

as

appropriate

for Reserve

Component

(RC)

(including

National

Guard)

personnel.

RC

(including

National Guard)

personnel

on offrcial

travel will complete

any

required

health

and ROM measures,

including

home-based

quarantine

or self-

isolation

if required,

prior

to

the end of the

official

duty

period.

a

RC

(including

National Guard)

personnel

on official travel

who are not eligible

for

treatment

at

a

military

medical treahrent

facility,

or who are not

within the

established

access radius

around

a military

medical treabnent facility,

may obtain

COVID-l9

official travel related

testing

at a civilian

testing site and

submit for

reimbursement

on their travel

voucher.

a

13

ATTACHMENT

2

References

(a)

Department

of

Defense

Instruction (DoDI)

6200.03,

"Public Health Emergency

Management

(PHEM)

Within

the DoD,"

March 28,2019

(b)

Under Secretary

of Defense

for Personnel

and Readiness

Memorandum,

"Force

Health

Protection

Guidance

(Supplement

l8)

Revision

I

-

Department

of

Defense

Guidance

for

Protecting

All Personnel

in

Department

of Defense

Worþlaces

During

the Coronavirus

Disease 2019

Pandemic,"

January

6,2022

(c)

Secretary

of Defense

Memorandum,

"Update

to

Conditions-based

Approach

to Coronavirus

Disease

2019

Personnel

Movement

and Travel

Reshictions,"

March

15,2021

(d)

Acting

Under

Secretary

of

Defense

for

Personnel

and Readiness

Memorandum,

"Force

Health Protection

Guidance

(Supplement2})

-

Department

of Defense

Guidance for

Personnel

Traveling

During

the

Coronavirus

Disease

2019 Pandemic,"

April 12,202I

(hereby

rescinded)

(e)

Acting

Under

Secretary of Defense

for

Personnel

and Readiness

Memorandum,

"Force

Health Protection

Guidance

(Supplement

16) Revision

1

-

Department

of Defense

Guidance

for Deployment

and Redeployment

of Individuals

and

Units During

the Coronavirus

Disease

2019 Pandemic,"

May 4,2021

(hercby

rescinded)

(Ð

Under

Secretary

of

Defense

for

Personnel

and Readiness

Memorandum,

"Force

Health

Protection

Guidance

(Supplement

15)

Revision

3

-

Department

of

Defense

Guidance

for

Coronavirus

Disease

2019 Laboratory

Testing

Services," December

30,2021

(g)

Acting

Under Secretary

of Defense

for Personnel

and Readiness

Memorandum,

"Force

Health

Protection

Guidance

(Supplement

17)

Revision

I

-

Department

of Defense

Guidance

for the

Use of Masks,

Personal

Protective

Equipment,

and

Non-Pharmaceutical

Interventions

During

the coronavirus

Disease

2019 Pandemic,"

June 22,2021

(h)

DoD

Joint Travel

Regulations,

current

edition

(i)

Acting

Under

Secretary

of

Defense

for

Personnel

and Readiness

Memorandum,

"Forca

Health Protection

Guidance

(Supplement

22)

-Department

of

Defense

Guidance

for

Coronavirus Disease

2019

Surveillance

and

Screening

with Testing,"

JuIy 21,2021

Ú)

DoD

Coronavirus

Task Force

Diagnostics

and Testing Lead

Memorandum, "Optimization

of Coronavirus

Disease20lg

(COVID-I9)

Testing Resources,"

March

8,202I

(k)

Director,

Defense

Health

Agency

Memorandum,

"supplemental

Health Care Program

Blanket

Vy'aiver

for Coronavirus

2019

(COVID-l9)

Testing

for Asymptomatic

Tier

1-4

Active Duty

Service

Members,"

August

27,2021

(l)

DoDI

6025.23, "Health

Care Eligibility

Under

the Secretarial

Designee

(SECDES)

Program

and Related

Special Authorities,"

September

16,2017

(m)

Executive

Order

13998, "Promoting

COVID-I9

Safety in

Domestic

and International

Travel,"

January 21,

2021

(n)

Centers for

Disease

Control

and Prevention

Federal

Register

Notice, "Requirement

for

Negative Pre-Deparfure

COVID-l9

Test

Result or Documentation

of Recovery

from

COVID-19

for

All Airline

or Other

Aircraft Passengers

Arriving into

the United

States from

any Foreign

Country,"

86

Federal

Register,

69256-69284, December

2,202I,

as amended

(o)

Under Secretary

of

Defense

for Personnel

and Readiness

Memorandum,

"Force

Health

Protection

Guidance

(Supplement23)

Revision

3- Department

of

Defense

Guidance

for

Coronavirus

Disease

2079 Yaccination

Attestation,

and Screening

Testing,

and Vaccination

Verification,"

December

20, 2021

14